Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 3
1988 3
1989 6
1990 1
1991 1
1992 1
1993 1
1994 3
1995 2
1996 2
1997 1
1998 6
1999 1
2000 3
2001 4
2002 2
2003 1
2004 4
2005 2
2006 1
2007 2
2008 3
2009 1
2010 4
2011 4
2012 6
2013 4
2014 4
2015 6
2016 9
2017 4
2018 6
2019 9
2020 7
2021 2
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, Mackie N, Bowman C, Lacey CJ, Apea V, Brady M, Fox J, Taylor S, Antonucci S, Khoo SH, Rooney J, Nardone A, Fisher M, McOwan A, Phillips AN, Johnson AM, Gazzard B, Gill ON. McCormack S, et al. Among authors: dunn dt. Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9. Lancet. 2016. PMID: 26364263 Free PMC article. Clinical Trial.
Mosaic effectiveness: measuring the impact of novel PrEP methods.
Glidden DV, Mehrotra ML, Dunn DT, Geng EH. Glidden DV, et al. Among authors: dunn dt. Lancet HIV. 2019 Nov;6(11):e800-e806. doi: 10.1016/S2352-3018(19)30227-9. Epub 2019 Sep 27. Lancet HIV. 2019. PMID: 31570273 Free PMC article. Review.
Improving clinical trial interpretation with ACCEPT analyses.
Clements MN, White IR, Copas AJ, Cornelius V, Cro S, Dunn DT, Quartagno M, Turner RM, Tweed CD, Walker AS. Clements MN, et al. Among authors: dunn dt. NEJM Evid. 2022 Jul 26;1(8):evidctw2200018. doi: 10.1056/EVIDctw2200018. eCollection 2022 Aug. NEJM Evid. 2022. PMID: 35965674 Free PMC article. No abstract available.
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2.
Szubert AJ, Pollock KM, Cheeseman HM, Alagaratnam J, Bern H, Bird O, Boffito M, Byrne R, Cole T, Cosgrove CA, Faust SN, Fidler S, Galiza E, Hassanin H, Kalyan M, Libri V, McFarlane LR, Milinkovic A, O'Hara J, Owen DR, Owens D, Pacurar M, Rampling T, Skene S, Winston A, Woolley J, Yim YTN, Dunn DT, McCormack S, Shattock RJ; COVAC 1 Study Team. Szubert AJ, et al. Among authors: dunn dt. EClinicalMedicine. 2023 Jan 13;56:101823. doi: 10.1016/j.eclinm.2022.101823. eCollection 2023 Feb. EClinicalMedicine. 2023. PMID: 36684396 Free PMC article.
HIV prevention trial design in an era of effective pre-exposure prophylaxis.
Cutrell A, Donnell D, Dunn DT, Glidden DV, Grobler A, Hanscom B, Stancil BS, Meyer RD, Wang R, Cuffe RL. Cutrell A, et al. Among authors: dunn dt. HIV Clin Trials. 2017 Nov-Dec;18(5-6):177-188. doi: 10.1080/15284336.2017.1379676. Epub 2017 Oct 17. HIV Clin Trials. 2017. PMID: 29039265 Free PMC article. Review.
125 results